Gilead DAAs safe, effective for adults with HCV, severe renal impairment

The FDA approved changes to the product labels for direct-acting antivirals Harvoni, Epclusa, and Vosevi to include new efficacy and safety data for adults with hepatitis C and severe renal impairment, including those who require dialysis.“The product labeling updates for Epclusa, Harvoni and Vosevi recognize the high unmet need for effective HCV treatments for patients…

Prevalence of advanced polyps similar at ages 45-49, 50-54 years

SAN ANTONIO — The increased prevalence of advanced adenoma and clinically significant serrated polyps was similar among age groups on both sides of age 50 years, suggesting that screening at 45 years optimizes colorectal cancer prevention, according to study results presented at the American College of Gastroenterology Annual Meeting.Lynn F. Butterly, MD, of Dartmouth-Hitchcock Medical…

Ambient light could improve end-of-day adenoma detection

SAN ANTONIO — Performing colonoscopies in a room with ambient light could improve the decrease in adenoma detection rate that generally occurs over the course of the beginning to the end of the day, according to study results presented at the American College of Gastroenterology Annual Meeting.Ryan T. Hoff, DO, of Advocate Lutheran General Hospital…

Healio Disruptive Innovators ‘On the Rise’ at ACG

During this year’s American College of Gastroenterology Annual Meeting in San Antonio, I had the honor of hosting the second annual Healio Disruptive Innovators Awards.This ceremony honored Disruptive Innovators in seven different categories, with each awardee changing the face of gastroenterology and pushing the status quo toward the betterment of the field.These awards were brought…

Healio Disruptive Innovators at ACG 2019

Healio Gastroenterology and Liver Disease unveiled its second annual Disruptive Innovators Awards recipients at the American College of Gastroenterology Annual Scientific Meeting.The publication honored Disruptive Innovators in seven categories for changing the face of gastroenterology and pushing the status quo toward the betterment of the field.Here are some of the tweets from those who attended…